Detalhe da pesquisa
1.
Residual cancer burden after neoadjuvant chemotherapy and long-term survival outcomes in breast cancer: a multicentre pooled analysis of 5161 patients.
Lancet Oncol
; 23(1): 149-160, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34902335
2.
Three-year follow-up of de-escalated axillary treatment after neoadjuvant systemic therapy in clinically node-positive breast cancer: the MARI-protocol.
Breast Cancer Res Treat
; 193(1): 37-48, 2022 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-35239072
3.
Pathologic response of ductal carcinoma in situ to neoadjuvant systemic treatment in HER2-positive breast cancer.
Breast Cancer Res Treat
; 189(1): 213-224, 2021 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-33945043
4.
Breast-Conserving Therapy in Patients with cT3 Breast Cancer with Good Response to Neoadjuvant Systemic Therapy Results in Excellent Local Control: A Comprehensive Cancer Center Experience.
Ann Surg Oncol
; 28(12): 7383-7394, 2021 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-33978889
5.
Minimally Invasive Complete Response Assessment of the Breast After Neoadjuvant Systemic Therapy for Early Breast Cancer (MICRA trial): Interim Analysis of a Multicenter Observational Cohort Study.
Ann Surg Oncol
; 28(6): 3243-3253, 2021 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-33263830
6.
ASO Author Reflections: Reducing Axillary Lymph Node Dissections in Node-Positive Breast Cancer Patients.
Ann Surg Oncol
; 25(Suppl 3): 677-678, 2018 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-30474766
7.
[18F]FDG-PET/CT in prone compared to supine position for optimal axillary staging and treatment in clinically node-positive breast cancer patients with neoadjuvant systemic therapy.
EJNMMI Res
; 11(1): 78, 2021 Aug 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-34417932